Cryoport (NASDAQ: CYRX)
Cryoport Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Cryoport Company Info
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
News & Analysis
Why Shares of Cryoport are Tumbling Thursday
The cold supply chain company released preliminary second-quarter earnings.
2 Ultra-High-Growth Healthcare Stocks That Are Just Getting Started
Both stocks are in the early stage of a long-term growth trajectory.
Why Cryoport Stock Is Up 39% Since Yesterday and Chart Industries Stock is Down
Cryoport is acquiring Chart's cryobiological business and getting a big boost from one of the giants in private equity.
Why Cryoport Stock Just Dropped 16%
Buckle up, shareholders, and prepare for a miss in Q4.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.